Lumigenix Inc.

📍 Sydney, Australia🗓 Founded 2010
Lumigenix provides genetic tests for health and ancestry. Using the latest genotyping technology, Lumigenix tests their customer’s DNA via a saliva sample and links their information to current genetic research, to provide an understanding of how their DNA has influenced their: - Predisposition to common diseases, including prostate cancer and Type 2 diabetes - Traits, such as caffeine metabolism and bitter taste perception - Ancestry, including their haplogroup and their ancestor’s path of migration. Information is provided through web-based tools, designed to be educative and delivered in an accessible, interesting and transparent way. The disease related information encompasses a risk report alongside peer-reviewed content from the Mayo Clinic.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2010
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Lumigenix Inc. founded?
Lumigenix Inc. was founded in 2010.
What industry is Lumigenix Inc. in?
Lumigenix Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Lumigenix Inc. based?
Lumigenix Inc. is headquartered in Sydney, Australia.